Community-Based Participatory Learning and Action Program to Prevent and Control Type II Diabetes in Urban Karachi, Pakistan A Feasibility Trial
Led by Baqai Institute of Diabetology and Endocrinology · Updated on 2024-08-26
240
Participants Needed
1
Research Sites
47 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a Participatory Learning and Action PLA based intervention to prevent and control Type II Diabetes Mellitus TIIDM and its risk factors in urban Karachi, Pakistan. This approach is adapted from a successful rural trial in Bangladesh and aims to address the growing health emergency of TIIDM, especially in low- and middle-income countries. The study focuses on community engagement to improve social and behavioral health determinants and manage diabetes more effectively in urban settings.
The intervention involves community mobilization through male and female groups who meet monthly over 18 months. These groups identify and prioritize diabetes-related issues, plan strategies to address them, implement these strategies, and evaluate their impact. A control group will not receive the PLA intervention but will receive information about the trial and guidance for managing hyperglycemia. This randomized trial compares outcomes between the intervention and control groups.
Participants will be assessed over 18 months with evaluations including diabetes prevalence, incidence, blood pressure, obesity, quality of life, and mental health aspects like depression and anxiety. The study includes questionnaires, physical measurements, and validated checks to monitor effectiveness and feasibility. The trial aims to provide insights into adapting PLA interventions in urban environments and contribute to diabetes prevention efforts.
CONDITIONS
Brief Title
Feasibility Trial in Urban Pakistan for Community Engagement in Preventing Type II Diabetes and Risk Factors
Research Team
A
Abdul Basit, Director
R
Rubia Zafar, TrialManager
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Residents of the randomized clusters in Karachi, Pakistan.
Willingness to participate and provide consent.
Includes people with normal blood sugar, intermediate hyperglycemia, or diabetes.
Ability to attend scheduled meetings and interventions as required by the study protocol.
You will not qualify if you...
Individuals under 20 years of age.
Unwilling to provide consent.
Severe health conditions that prevent active participation.
Non-compliance with research protocols.
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Outpatient Treatment
Duration - 18 months
Participants in the intervention group attend monthly community group meetings where they engage in participatory learning and action cycles to identify, plan, and address diabetes-related problems.
Monthly meetings over 18 months
Long-term Monitoring
Duration - Assessment at 18 months
Participants are evaluated after the 18-month intervention period to assess the effectiveness and feasibility of the intervention.
1 follow-up visit (in-person) after 18 months
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Randomized, Double-Blind, Placebo-Controlled Study to Find the Best Dose of CX11 Tablets for Adults with Type 2 Diabetes
Phase II Study of Weekly GL0034 Injections to Treat Overweight or Obese Adults With Type II Diabetes
Community-Based Participatory Learning and Action to Prevent and Control Type II Diabetes in Rural Kabul, Afghanistan A Feasibility Trial
Community-Based Participatory Learning and Action to Prevent and Control Type II Diabetes and Its Risk Factors in Rural Pakistan A Cluster Randomized Trial
Community-Based Participatory Learning and Action Program to Prevent and Control Type II Diabetes in Urban Karachi, Pakistan A Feasibility Trial
Safety and Effectiveness of Empagliflozin With or Without Metformin in Adults Aged 18 to 65 with Type II Diabetes
Phase 1 Study to Understand How Kidney Problems Affect the Bodys Handling of GL0034 in Adults with Type 2 Diabetes
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Engagement of coMmunity through Participatory learning and action for cOntrol and preVEntion of Type 2 Diabetes and its Risk factors (EMPOWER-D): protocol for a feasibility cluster randomised controlled trial in urban Pakistan.
Engaging communities through participatory learning action for the control and prevention of diabetes: A protocol for the Process Evaluation of the EMPOWER-D trial in Pakistan and Afghanistan.